MRD Monitoring in Acute Lymphoblastic Leukemia
0 Visninger
• 06/15/23
0
0
Indlejre
administrator
Abonnenter
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer